Search research articles
Contact Us
Filters
Showing results (201-210 of 245) with videos related to
Page
of 25
Sort By:
Journal of Burn Care & Research : Official Publication of the American Burn Association
|
September 5, 2014
Determination of Optimal Amikacin Dosing Regimens for Pediatric Patients With Burn Wound Sepsis
Tian Yu, Chris Stockmann, Daniel P Healy, et al.
Antimicrobial Agents and Chemotherapy
|
August 2, 2017
Tools for the Individualized Therapy of Teicoplanin for Neonates and Children
V Ramos-Martín, M N Neely, K Padmore, et al.
Antimicrobial Agents and Chemotherapy
|
July 1, 2020
Population Pharmacokinetics and Target Attainment of Cefepime in Critically Ill Patients and Guidance for Initial Dosing
Mohammad H Al-Shaer, Michael N Neely, Jiajun Liu, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association
|
December 9, 2008
Are topical antimicrobials effective against bacteria that are highly resistant to systemic antibiotics?
Alice N Neely, Jason Gardner, Paula Durkee, et al.
Pediatrics
|
April 12, 2012
More codeine fatalities after tonsillectomy in North American children
Lauren E Kelly, Michael Rieder, John van den Anker, et al.
Scientific Reports
|
November 2, 2017
Sofosbuvir (SOF) Suppresses Ledipasvir (LDV)-resistant Mutants during SOF/LDV Combination Therapy against Genotype 1b Hepatitis C Virus (HCV)
Ashley N Brown, Lin Liu, Jaime L Rodriquez, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association
|
November 25, 2010
Pharmacokinetics of colistin in an adolescent boy with extensive burn injury
Daniel P Healy, Amy D Sombun, Jason C Gardner, et al.
Clinical and Translational Science
|
March 13, 2024
Genetic predisposition and high exposure to colistin in the early treatment period as independent risk factors for colistin-induced nephrotoxicity
Sumith K Mathew, Aaron Chapla, Padmanaban Venkatesan, et al.
The Journal of Antimicrobial Chemotherapy
|
August 21, 2016
Population pharmacokinetics and pharmacodynamics of teicoplanin in neonates: making better use of C-reactive protein to deliver individualized therapy
V Ramos-Martín, M N Neely, P McGowan, et al.
Antimicrobial Agents and Chemotherapy
|
September 22, 2020
Developing New Drugs for Mycobacterium tuberculosis Therapy: What Information Do We Get from Preclinical Animal Models?
G L Drusano, Brandon Duncanson, C A Scanga, et al.
Page
of 25
Search research articles
Search
Showing results (201-210 of 245) with videos related to
Sort By:
Page
of 25
Journal of Burn Care & Research : Official Publication of the American Burn Association
|
September 5, 2014
Determination of Optimal Amikacin Dosing Regimens for Pediatric Patients With Burn Wound Sepsis
Tian Yu, Chris Stockmann, Daniel P Healy, et al.
Antimicrobial Agents and Chemotherapy
|
August 2, 2017
Tools for the Individualized Therapy of Teicoplanin for Neonates and Children
V Ramos-Martín, M N Neely, K Padmore, et al.
Antimicrobial Agents and Chemotherapy
|
July 1, 2020
Population Pharmacokinetics and Target Attainment of Cefepime in Critically Ill Patients and Guidance for Initial Dosing
Mohammad H Al-Shaer, Michael N Neely, Jiajun Liu, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association
|
December 9, 2008
Are topical antimicrobials effective against bacteria that are highly resistant to systemic antibiotics?
Alice N Neely, Jason Gardner, Paula Durkee, et al.
Pediatrics
|
April 12, 2012
More codeine fatalities after tonsillectomy in North American children
Lauren E Kelly, Michael Rieder, John van den Anker, et al.
Scientific Reports
|
November 2, 2017
Sofosbuvir (SOF) Suppresses Ledipasvir (LDV)-resistant Mutants during SOF/LDV Combination Therapy against Genotype 1b Hepatitis C Virus (HCV)
Ashley N Brown, Lin Liu, Jaime L Rodriquez, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association
|
November 25, 2010
Pharmacokinetics of colistin in an adolescent boy with extensive burn injury
Daniel P Healy, Amy D Sombun, Jason C Gardner, et al.
Clinical and Translational Science
|
March 13, 2024
Genetic predisposition and high exposure to colistin in the early treatment period as independent risk factors for colistin-induced nephrotoxicity
Sumith K Mathew, Aaron Chapla, Padmanaban Venkatesan, et al.
The Journal of Antimicrobial Chemotherapy
|
August 21, 2016
Population pharmacokinetics and pharmacodynamics of teicoplanin in neonates: making better use of C-reactive protein to deliver individualized therapy
V Ramos-Martín, M N Neely, P McGowan, et al.
Antimicrobial Agents and Chemotherapy
|
September 22, 2020
Developing New Drugs for Mycobacterium tuberculosis Therapy: What Information Do We Get from Preclinical Animal Models?
G L Drusano, Brandon Duncanson, C A Scanga, et al.
Page
of 25